Free Trial

Immatics (IMTXW) Competitors

Immatics logo
$0.19 -0.05 (-20.83%)
(As of 05:16 PM ET)

IMTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDW

Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry.

Immatics vs.

Immatics (NASDAQ:IMTXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.

Immatics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
ImmaticsN/AN/A
180 Life SciencesN/AN/A

Company Net Margins Return on Equity Return on Assets
ImmaticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Immatics' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Immatics Neutral
180 Life Sciences Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Immatics$115.50MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Summary

Immatics beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMTXW vs. The Competition

MetricImmaticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$204.90M$5.01B$9.08B
Dividend YieldN/A3.50%4.87%4.17%
P/E RatioN/A315.10135.4317.18
Price / SalesN/A15,187.911,119.53115.67
Price / CashN/A11.8140.5837.88
Price / BookN/A7.304.754.78
Net IncomeN/A-$18.37M$118.50M$225.60M
7 Day Performance-36.67%-0.64%-1.83%-1.26%
1 Month Performance-58.70%128.99%12.27%4.37%
1 Year Performance-92.40%118.04%31.72%18.73%

Immatics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMTXW
Immatics
N/A$0.19
-20.8%
N/A-91.5%$0.00$115.50M0.00260Gap Down
ATNFW
180 Life Sciences
N/A$0.01
-8.5%
N/A+25.0%$0.00N/A0.007Gap Up
LBPSW
4D pharma
N/A$0.04
-25.7%
N/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.16
+6.2%
N/A+4.1%$0.00N/A0.002
AIMDW
Ainos
N/A$0.03
-42.9%
N/AN/A$0.00$40,633.000.0040News Coverage
Positive News
Gap Down
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+41.4%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.3978 of 5 stars
$12.06
+2.2%
$18.00
+49.3%
+11.2%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
+50.0%
N/A+1.2%$0.00N/A0.004High Trading Volume
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/A-23.6%$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
-0.1%
N/A+1,700.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/AN/A$0.00$193.06M0.00N/AGap Up

Related Companies and Tools


This page (NASDAQ:IMTXW) was last updated on 12/20/2024 by MarketBeat.com Staff
From Our Partners